Paul Richard Rhomberg

6PUBLICATIONS
10CO-AUTHORS
Medical mycologyClinical microbiologyInfant and child healthMedical infection agents (incl. prions)Cheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 19, 2026
Activity of manogepix and comparator antifungal agents against uncommon filamentous fungal isolates collected in a global surveillance program.

|Aug 27, 2026
In Vitro Antimicrobial Activity of Taurolidine Against Isolates Associated with Catheter-Related Bloodstream Infections.

|Jun 15, 2022
Activity of Tedizolid and Comparator Agents Against Gram-positive Isolates Causing Skin and Skin Structure Infections in Pediatric Patients in United States Hospitals (2015-2019).

Cecilia Godoy Carvalhaes, Helio Silva Sader, Paul Richard Rhomberg

|May 05, 2022
Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections.

Michael A Pfaller, Cecilia G Carvalhaes, Sean DeVries

|Mar 07, 2022
Evaluation of Rezafungin Provisional CLSI Clinical Breakpoints and Epidemiological Cutoff Values Tested against a Worldwide Collection of Contemporaneous Invasive Fungal Isolates (2019 to 2020).

Cecilia G Carvalhaes, Abby L Klauer, Paul R Rhomberg

|Oct 20, 2020
In Vitro Activity Analysis of a New Polymyxin, SPR741, Tested in Combination with Antimicrobial Agents against a Challenge Set of Enterobacteriaceae, Including Molecularly Characterized Strains.

Rodrigo E Mendes, Paul R Rhomberg, Troy Lister

Pageof 1

Frequent Collaborators

6 joint publications

Mariana Castanheira

3 joint publications

Cecilia Godoy Carvalhaes

2 joint publications

Rodrigo Elisandro Mendes

2 joint publications

Michael A Pfaller